INTRODUCTION AND OBJECTIVES: Prostate Cancer (PCa) is the most common cancer diagnosed in males and the second leading cause of death from cancer in men. Despite the advances in cancer therapy, when PCa progress to castration resistant phase, patients develop incurable bone metastases. Therefore, understanding of the processes that regulate homing and survival of metastatic cancer cells in the bone is crucial for the identification of new therapies. TGF-b signaling plays a major role in bone remodeling and according to the 00 vicious cycle hypothesis 00 is a master regulator of maintenance of prostate cancer cells in lytic bone lesions. microRNAs (miRs) are a class of small non-coding RNAs that regulates many biological process. miR-221 expression has been previously associated with prostate cancer progression. Here we studied the effect of miR-221 on TGF-b signaling and the impact of miR-221 on tumor growth in vivo.
METHODS: miR-221 was overexpressed in PC3 and RWPE-1 cells and PMEPA was monitored by RT-qPCR and western blot. Expression of miR-221 in PC3 and RWPE-1 cells was assessed by RT-qPCR. Predicted targets were identified in silico (Targetscan and microRNA.org). Luciferase assay was used to investigate the interaction between miR-221 and PMEPA1. For zebrafish experiment, fluorescently labelled PC-3M-Pro4 cells overexpressing miR-221 were injected in the duct of cuvier of zebrafish embryos.
RESULTS: We found that miR-221 overexpression resulted in decreased PMEPA1 mRNA and protein in PC-3 human prostate cancer cells. PMEPA1 is a master regulator of TGF-b signaling and luciferase reporter assay revealed that miR-221 can directly interact with PMEPA1 3 0 UTR. Our experiments showed an enhancement of the proliferative effect of TGF-b in PC-3 cells, following enforced miR-221 expression. In conclusion, we observed increased Smad2 activation upon TGF-b treatment in miR-221 overexpressing PC-3 cells. Inoculation of fluorescently labelled highly metastatic PC-3M-Pro4 cells overexpressing miR-221 in the Duct of Cuvier (DC) of zebrafish embryos resulted reduced tumor burden compared to control. Finally, we found an inverse correlation between miR-221 and PMEPA1 expression in normal vs. tumor tissue collected from PCa patients.
CONCLUSIONS: Our results indicate that miR-221 is a regulator of TGF-b signaling via modulation of PMEPA1 and miR-221 overexpression can reduce tumor growth in vivo. Therefore, miR-221 represents an interesting molecule to target PCa and to interfere with the maintenance of PCa cells in the bone microenvironment. . 197, No. 4S, Supplement, Tuesday, May 16, 2017 
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